TargetThymocyte selection-associated high mobility group box protein TOX(Human)
Aerie Pharmaceuticals
US Patent
Aerie Pharmaceuticals
US Patent
Affinity DataIC50: 5.52E+4nMAssay Description:Inhibition of various kinases was assayed.More data for this Ligand-Target Pair
TargetThymocyte selection-associated high mobility group box protein TOX(Human)
Aerie Pharmaceuticals
US Patent
Aerie Pharmaceuticals
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of various kinases was assayed.More data for this Ligand-Target Pair
TargetThymocyte selection-associated high mobility group box protein TOX(Human)
Aerie Pharmaceuticals
US Patent
Aerie Pharmaceuticals
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of various kinases was assayed.More data for this Ligand-Target Pair
TargetThymocyte selection-associated high mobility group box protein TOX(Human)
Aerie Pharmaceuticals
US Patent
Aerie Pharmaceuticals
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of various kinases was assayed.More data for this Ligand-Target Pair
TargetThymocyte selection-associated high mobility group box protein TOX(Human)
Aerie Pharmaceuticals
US Patent
Aerie Pharmaceuticals
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of various kinases was assayed.More data for this Ligand-Target Pair
TargetThymocyte selection-associated high mobility group box protein TOX(Human)
Aerie Pharmaceuticals
US Patent
Aerie Pharmaceuticals
US Patent
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of various kinases was assayed.More data for this Ligand-Target Pair
